There is no such thing as iron supplements: they are forbidden even for a pregnant woman with anaemia, because a diet that needs supplements is deficient.
Original statement
رفضوا رفضوا تناول مكملات الحديد للحامل مع وجود انيميا ممنوع يا استاذه ممنوع مافيش حاجه اسمها مكملات حديد ما فيش حاجه اسمها مكملات النظام الغذائي اللي محتاج مكملات يبقى ناقص
verbatim according to source. Translation by the project; the Arabic wording is authoritative.
Translation
There is no such thing as iron supplements: they are forbidden even for a pregnant woman with anaemia, because a diet that needs supplements is deficient.
Origin
- Source status
- Video transcript (own words)
- Attribution
- Elawady (machine transcript)
- Video
- Dr Diaa Al Awady د ضياء العوضي is live! الموت المفاجيء (Open source)
- Published
- 14 July 2025
- Timestamp
- 0:00:06 (location in the original video’s automatic YouTube caption track; confirms where the words occur, not who speaks)
- Attribution uncertainty
- Machine transcript of a live stream; the first sentence appears to be read from a viewer's comment, followed by Elawady's reply ('forbidden, madam, forbidden'). The exact speaker attribution of each phrase is uncertain.
- Claimed mechanism
The diet should provide everything; supplements signal a flawed diet.
- Claimed health effect
Avoidance of iron supplements in pregnancy.
- Population concerned
Pregnant women with anaemia.
- Geographic restriction by Elawady
none found
Diverging source versions
ممنوع أي أدوية كيميائية: خافض الحرارة، المسكنات، الفيتامينات، المكملات الصناعية، أدوية الحموضة، الأسبرين ويجب استشارة طبيبك الخاص وتحت اشرافه
- Source status
- Third-party site (unofficial)
- Attribution
- Third-party site (unofficial by its own statement)
- Origin
- https://mytayibat.com/forbidden
- Attribution uncertainty
- Lowest attribution level; the site states it is unofficial.
Scientific assessment
False – The statement contradicts the robust evidence.
Certainty of evidence: moderate – Further research may still affect the assessment.
1. What was claimed?
No iron supplements, even for anaemic pregnant women.
2. What is demonstrably correct?
Diet quality matters, and iron supplements can cause gastrointestinal side effects; supplements are not needed by everyone.
3. What is wrong or exaggerated?
Refusing iron to a pregnant woman with anaemia contradicts standard care; trials show iron supplements reduce anaemia and iron deficiency in pregnancy. Iron needs rise sharply in pregnancy and often cannot be met by diet alone.
4. What remains unclear?
Effects of routine (non-indicated) iron on birth outcomes are less clear (Cochrane: low birthweight and preterm birth reductions not statistically significant).
5. Which studies support it?
No good evidence supports withholding iron. A small systematic review of 7 trials (I-SUP-123) found that dietary interventions, often using iron-fortified foods, can raise haemoglobin; it does not show that diet can replace iron tablets when anaemia is present.
6. Which studies contradict it?
Finkelstein 2024 Cochrane update (I-SUP-101; supersedes I-SUP-04): iron-deficiency anaemia at term RR 0.41, low birthweight RR 0.84. Haider 2013 (I-SUP-102): anaemia early in pregnancy associated with low birthweight (OR 1.29) and preterm birth (OR 1.21); iron reduces anaemia with a dose-response. Reveiz 2011 Cochrane (I-SUP-109): oral iron corrects anaemia in pregnant women with iron-deficiency anaemia. Watt 2025 (I-SUP-104): even in non-anaemic women iron halves anaemia (NNT 10). WHO eLENA recommendation (I-SUP-105).
7. What applies to Germany and Europe?
German maternity care routinely checks haemoglobin and treats iron deficiency.
8. What is known about Egypt?
A 2025 meta-analysis of 18 Egyptian studies (14,548 women; I-LEG-127) found anaemia in 49% of pregnant women (65% in the third trimester); lack of iron supplementation was associated with anaemia (OR 2.59). The claim therefore concerns a very common condition in Egypt.
9. What practical conclusion is appropriate?
Pregnant women with anaemia should follow their obstetric care plan, which usually includes iron.
Assessment details
- Rationale for certainty of evidence
Cochrane review update 2024 (57 trials, 48,971 women; I-SUP-101): daily iron reduced iron-deficiency anaemia at term from 18.4% to 5.0% (RR 0.41, 0.26-0.63; moderate certainty) and maternal anaemia (RR 0.30, 0.20-0.47; low certainty) and slightly reduced low birthweight (RR 0.84, 0.72-0.99; moderate). Treatment trials in women with diagnosed iron-deficiency anaemia are small but show correction of anaemia (I-SUP-109). WHO recommends daily iron (30-60 mg) and folic acid for all pregnant women (I-SUP-105). Certainty for hard clinical outcomes (maternal death, preterm birth) is lower, so overall certainty stays moderate.
- Source quality
Video statement; safety-critical.
- Regional transferability
Applies everywhere; anaemia in pregnancy is common in many countries.
- Individual exceptions
Women with iron overload (e.g. haemochromatosis) or certain haemoglobinopathies need individual assessment.
- Regional scope of the claim
- general (biological/medical)
- Last reviewed
- 26 October 2026 provisional
Scientific evidence in detail
Scientifically refuted – High-quality evidence shows the opposite, or the claim contradicts well-established physiology.
Research question: In pregnant women with anaemia (mostly iron deficiency), does oral iron supplementation, compared with no iron or placebo, correct anaemia and improve maternal/infant outcomes, and is withholding iron justified?
Research question in detail (PICO)
- Population
- Pregnant women with or at risk of anaemia
- Intervention or exposure
- Oral iron (with or without folic acid)
- Comparison
- No iron / placebo / diet only
- Geographic scope
- universal biology; high regional burden in Egypt
- Outcomes
- Maternal anaemia and iron-deficiency anaemia at term
- Low birthweight
- Preterm birth
- Adverse effects
Study results as reported by the authors. Our assessment follows below.
What speaks for the claim?
Diet to treat anaemia in pregnancy
Skolmowska D et al.. Nutrients 2022 · PMID 35893877 · DOI 10.3390/nu14153023 Systematic reviewabstract checkednewly addedSystematic review of 7 small RCTs: dietary interventions (partly with iron-fortified foods) raised haemoglobin in pregnancy.
- Actual result
- All interventions reported effective (not pooled).
- Methodological quality
- low (small, medium-high risk of bias trials)
- Relevance
- indirect (fortified foods contain added iron; not a test of withholding iron)
- Limitations
- Does not compare diet with iron tablets in anaemia.
What speaks against the claim?
Iron tablets in pregnancy: updated Cochrane review
Finkelstein JL et al.. Cochrane Database Syst Rev 2024 · PMID 39145520 · DOI 10.1002/14651858.CD004736.pub6 Meta-analysisabstract checkednewly addedCochrane 2024 (57 trials, 48,971 women): iron reduces anaemia and iron-deficiency anaemia at term.
- Actual result
- IDA at term 5.0% vs 18.4%, RR 0.41 (0.26-0.63; moderate); LBW RR 0.84 (0.72-0.99).
- Methodological quality
- high
- Relevance
- direct
- Limitations
- Mostly preventive supplementation.
WHO: iron and folic acid for every pregnancy
World Health Organization. WHO eLENA (web page) 2024 Guideline / position statementabstract checkednewly addedWHO recommends daily iron and folic acid for all pregnant women.
- Actual result
- 30-60 mg iron + 400 micrograms folic acid daily.
- Methodological quality
- authoritative guideline
- Relevance
- direct
- Limitations
- Web summary read.
Treating iron-deficiency anaemia in pregnancy
Reveiz L et al.. Cochrane Database Syst Rev 2011 · PMID 21975735 · DOI 10.1002/14651858.CD003094.pub3 Systematic reviewabstract checkednewly addedCochrane: oral iron corrects iron-deficiency anaemia in pregnancy; GI side effects common.
- Actual result
- Anaemia RR 0.38 (0.26-0.55) in one trial.
- Methodological quality
- moderate review of weak trials
- Relevance
- direct (anaemic women)
- Limitations
- Small, poor-quality trials.
What does the overall evidence say?
Editorial assessment based on the studies above – not itself a study result.
Which position is better supported?
Iron is effective and recommended for preventing and treating iron-deficiency anaemia in pregnancy; withholding it from an anaemic pregnant woman contradicts evidence and guidelines.
Why some studies weigh more
Cochrane reviews and WHO guidance weigh most; the dietary-intervention review is small, biased and partly uses fortified foods.
Is a causal relationship established? Yes, established Randomised trials show iron reduces anaemia and iron deficiency; clinical outcomes less certain.
Remaining uncertainty
Effect on hard clinical outcomes; optimal dose; harms.
Justified conclusion
The claim is false and potentially harmful.
Why do studies seem to disagree?
No real conflict: diet-based approaches can help but have not been shown to replace iron when anaemia is present.
Does this depend on the country?
- General biological effects
- Iron needs rise sharply in pregnancy everywhere.
- Eating habits
- Diets low in meat and high in tea are associated with anaemia in Egyptian studies (I-LEG-127).
- Origin of the food
- Not relevant.
- Contaminants
- Not relevant.
- National production conditions
- Not relevant.
- Legal rules
- WHO recommendation global; national guidance not fetched.
- Actual monitoring data
- Egypt: pooled prevalence of anaemia in pregnancy 49% (I-LEG-127).
A regional difference is supported by robust data.
Statistical re-check
- ARR/NNT from reported proportions; CI symmetry – IDA at term ARR 13.4 points (NNT about 7); anaemia ARR 3.4 points (NNT about 29); LBW ARR 0.9 points (NNT about 111); CIs log-symmetric; crude anaemia ratio 0.54 vs pooled RR 0.30 (random-effects averaging). recalculated
- Implied baseline risk from NNT – RR 0.50 and NNT 10 imply control anaemia risk about 20%; consistent. recalculated
Certainty of the overall evidence (GRADE, simplified)
- Main outcome
- Iron-deficiency anaemia at term with iron supplementation
- Starting level
- high (randomised trials)
- Reasons for downgrading
- inconsistency (heterogeneity)
- Result
- moderate
Simplified assessment by a single reviewer, following the GRADE approach; not a formal GRADE panel. GRADE rates the body of evidence for one outcome, not individual studies.
Clinical guidelines and official statements checked
- WHO: Daily iron and folic acid supplementation during pregnancy (eLENA; recommendation from WHO antenatal care guideline 2016) (2024) · Original publication
Daily oral iron (30-60 mg elemental iron) and folic acid (400 micrograms) are recommended for pregnant women to prevent maternal anaemia, puerperal sepsis, low birth weight and preterm birth; folic acid should start as early as possible, ideally before conception, to prevent neural tube defects.
Search strategy
Documented literature searches for this review (search strings in the original database syntax).
| Database | Date | Search | Looking for | Hits | Included |
|---|---|---|---|---|---|
| Europe PMC | 26 October 2026 | (TITLE:"iron supplementation" OR TITLE:"iron supplements") AND TITLE:pregnan* AND (PUB_TYPE:"Systematic Review" OR PUB_TYPE:"Meta-Analysis" OR JOURNAL:"Cochrane Database Syst Rev") AND PUB_YEAR:[2018 TO 2026] | contradicting evidence | 7 | |
| Europe PMC | 26 October 2026 | TITLE:"iron deficiency anaemia" AND TITLE:pregnan* AND (TITLE:treatment OR TITLE:treatments) AND JOURNAL:"Cochrane Database Syst Rev" | contradicting evidence | 4 | |
| PubMed | 26 October 2026 | iron[ti] AND (pregnan*[ti]) AND (anaemia[ti] OR anemia[ti]) AND (systematic review[pt] OR meta-analysis[pt]) AND 2018:2026[dp] | contradicting evidence | 21 | |
| Europe PMC | 26 October 2026 | TITLE:"iron" AND TITLE:pregnan* AND (TITLE:harm OR TITLE:"adverse" OR TITLE:"gestational diabetes" OR TITLE:"haemoglobin concentration" OR TITLE:"hemoglobin concentration" OR TITLE:"high hemoglobin") AND (PUB_TYPE:"Meta-Analysis" OR PUB_TYPE:"Systematic Review") | supporting evidence | 3 | |
| Europe PMC | 26 October 2026 | (TITLE:"dietary" OR TITLE:"food-based" OR TITLE:"diet") AND (TITLE:anaemia OR TITLE:anemia OR TITLE:"iron status") AND TITLE:pregnan* AND (TITLE:intervention* OR TITLE:"without supplement*" OR TITLE:education) AND (PUB_TYPE:"Systematic Review" OR PUB_TYPE:"Meta-Analysis" OR PUB_TYPE:"Randomized Controlled Trial") | supporting evidence | 1 | |
| PubMed | 26 October 2026 | (iron supplement*[tiab]) AND pregnan*[tiab] AND (harm*[tiab] OR adverse[tiab] OR "gestational diabetes"[tiab] OR "high hemoglobin"[tiab]) AND (systematic review[pt] OR meta-analysis[pt]) | supporting evidence | 26 | |
| Europe PMC | 26 October 2026 | (TITLE:anaemia OR TITLE:anemia) AND (TITLE:pregnant OR TITLE:pregnancy) AND (TITLE:Egypt OR TITLE:Egyptian) | both directions | 5 | |
| WHO website | 26 October 2026 | https://www.who.int/tools/elena/interventions/daily-iron-pregnancy (fetched) | guidelines | 1 |
Open questions
Egyptian national antenatal guidance (Ministry of Health) not fetched. Whether the Egyptian meta-analysis (I-LEG-127) included the 2026-retracted Menoufia study (PMID 25643259).
How deeply was this checked?
8 linked studies: 0 checked in full text (0 of them with a structured risk-of-bias assessment), 8 on the basis of the abstract, 0 bibliographically only. No formal assessment with two independent reviewers and no independent human expert review has taken place yet.
Last scientific review: 26 October 2026
History of the verdict
- 25 October 2026 · Phase 1 · Initial assessment: False (moderate)
- 26 October 2026 · Phase 4 (systematic evidence review) · Re-examined with extended evidence; verdict unchanged: False (moderate)
The 2024 Cochrane update, WHO recommendation and Egyptian prevalence data strengthen the existing verdict; certainty for clinical outcomes stays moderate. Bottom line and safety note sharpened.
New sources: I-SUP-101 I-SUP-102 I-LEG-127 I-SUP-104 I-SUP-105 I-SUP-109 I-SUP-123
In plain language
During pregnancy the body needs much more iron, and many women become anaemic. Studies show that iron tablets reduce anaemia in pregnancy. Telling an anaemic pregnant woman not to take iron can harm her and her baby.
Studies on this claim
Studies supporting the claim (0)
No studies in this group.
Studies contradicting or limiting the claim (7)
-
Iron in pregnancy (Cochrane)
Peña-Rosas JP et al.. Cochrane Database Syst Rev 2015 · PMID 26198451 · DOI 10.1002/14651858.CD004736.pub5Meta-analysisindependent cross-checkabstract checked★ key studyDaily iron reduced anaemia at term by 70%.
Does the study support the specific claim? No · Methodological quality: high · Certainty of evidence: see overall assessment of the claim
Original publication · Scientific details
Study explained simply
- What did the researchers want to find out?
Iron in pregnancy.
- How was the study done?
Cochrane.
- How many people, animals or samples were studied?
43,274 women.
- What was actually found?
Less anaemia.
- How large was the observed effect?
RR 0.30.
- What do the results mean in everyday life?
Iron helps pregnant women.
- What are the study's limitations?
Low-quality evidence.
- What does it say about Elawady's specific claim?
Contradicts C-SUP-09.
- Do the results apply to Germany and Europe?
Applicable.
- What can explicitly not be concluded from this study?
Birth outcome benefits.
-
Iron tablets in pregnancy: updated Cochrane review
Finkelstein JL et al.. Cochrane Database Syst Rev 2024 · PMID 39145520 · DOI 10.1002/14651858.CD004736.pub6Meta-analysisindependent cross-checkabstract checked★ key studyIn 57 trials with almost 49,000 pregnant women, daily iron reduced iron-deficiency anaemia at term from 18.4% to 5.0% and slightly reduced low birthweight.
Iron reduces maternal anaemia and iron-deficiency anaemia at term (moderate certainty for IDA).
Does the study support the specific claim? No · Methodological quality: high · Certainty of evidence: see overall assessment of the claim
Original publication · Scientific details
Study explained simply
- What did the researchers want to find out?
To summarise all trials of daily iron tablets in pregnancy.
- How was the study done?
Systematic review and meta-analysis of randomised trials (Cochrane, 2024).
- How many people, animals or samples were studied?
57 trials, 48,971 women.
- What was actually found?
Less anaemia and iron deficiency at term; slightly fewer low-birthweight babies; no clear effect on deaths or preterm birth.
- How large was the observed effect?
Iron-deficiency anaemia RR 0.41 (0.26-0.63); anaemia RR 0.30 (0.20-0.47); low birthweight RR 0.84 (0.72-0.99).
- What do the results mean in everyday life?
Iron tablets in pregnancy work for their main purpose: preventing and correcting iron deficiency and anaemia.
- What are the study's limitations?
Mostly preventive use; harms poorly reported; heterogeneity.
- What does it say about Elawady's specific claim?
Contradicts the claim that iron supplements are forbidden or unnecessary in pregnancy.
- Do the results apply to Germany and Europe?
Applicable.
- What can explicitly not be concluded from this study?
It does not show that every pregnant woman needs iron, nor that iron prevents deaths.
-
Anaemia and iron in pregnancy: meta-analysis
Haider BA et al.. BMJ 2013 · PMID 23794316 · DOI 10.1136/bmj.f3443Meta-analysisindependent cross-checkabstract checkedIron tablets halved anaemia in pregnancy, and anaemia early in pregnancy was linked to more low-birthweight and preterm babies.
Anaemia in pregnancy is associated with low birthweight and preterm birth; iron reduces anaemia with a dose-response.
Does the study support the specific claim? No · Methodological quality: moderate · Certainty of evidence: see overall assessment of the claim
Original publication · Scientific details
Study explained simply
- What did the researchers want to find out?
To link anaemia and iron use in pregnancy with outcomes for mother and baby.
- How was the study done?
Meta-analysis of 48 trials and 44 cohort studies.
- How many people, animals or samples were studied?
17,793 women in trials; 1.85 million in cohorts.
- What was actually found?
Iron reduced anaemia and low birthweight; anaemic mothers had more small and preterm babies.
- How large was the observed effect?
Anaemia RR 0.50; low birthweight RR 0.81; anaemia-low birthweight OR 1.29.
- What do the results mean in everyday life?
Anaemia in pregnancy is not harmless, and iron corrects it.
- What are the study's limitations?
Older search; cohort data observational.
- What does it say about Elawady's specific claim?
Contradicts refusing iron to anaemic pregnant women.
- Do the results apply to Germany and Europe?
Applicable.
- What can explicitly not be concluded from this study?
Cannot show that anaemia itself causes preterm birth.
-
Anaemia in pregnant women in Egypt
Azzam A et al.. BMC Pregnancy Childbirth 2025 · PMID 39810098 · DOI 10.1186/s12884-024-07111-9Meta-analysisindependent cross-checkabstract checked★ key studyAbout half of pregnant women in Egyptian studies had anaemia measured by blood tests.
Regional burden: about half of pregnant women in Egypt are anaemic; lack of iron supplementation is a determinant.
Does the study support the specific claim? No · Methodological quality: moderate · Certainty of evidence: see overall assessment of the claim
Original publication · Scientific details
Study explained simply
- What did the researchers want to find out?
Estimate anaemia in pregnancy.
- How was the study done?
Meta-analysis.
- How many people, animals or samples were studied?
18 studies, 14,548 women.
- What was actually found?
49% anaemic.
- How large was the observed effect?
49% (42-57).
- What do the results mean in everyday life?
Anaemia is common and must be diagnosed with a blood test.
- What are the study's limitations?
Heterogeneous studies.
- What does it say about Elawady's specific claim?
Contradicts dismissing anaemia as gas.
- Do the results apply to Germany and Europe?
Egypt-specific.
- What can explicitly not be concluded from this study?
It does not test the gas hypothesis directly.
-
Iron for pregnant women who are not anaemic
Watt A et al.. Fam Pract 2025 · PMID 39834271 · DOI 10.1093/fampra/cmae079Meta-analysisindependent cross-checkabstract checkedIron tablets halved the risk of becoming anaemic (1 in 10 women helped), but did not change birthweight or preterm birth in women who started without anaemia.
Iron halves anaemia even in non-anaemic pregnant women; birth outcomes unchanged in this group.
Does the study support the specific claim? Partly · Methodological quality: moderate · Certainty of evidence: see overall assessment of the claim
Original publication · Scientific details
Study explained simply
- What did the researchers want to find out?
To weigh benefits and harms of routine iron in non-anaemic pregnancy.
- How was the study done?
Systematic review and meta-analysis.
- How many people, animals or samples were studied?
23 studies, 4,492 women.
- What was actually found?
Less anaemia; no effect on birth outcomes; harms poorly reported.
- How large was the observed effect?
Anaemia RR 0.50 (0.34-0.74), NNT 10.
- What do the results mean in everyday life?
Iron helps prevent anaemia even in women who start with normal blood counts.
- What are the study's limitations?
Small studies; harms data weak.
- What does it say about Elawady's specific claim?
Contradicts a ban on iron; partly supports that not every outcome improves.
- Do the results apply to Germany and Europe?
Applicable.
- What can explicitly not be concluded from this study?
Cannot settle whether all pregnant women should take iron.
-
WHO: iron and folic acid for every pregnancy
World Health Organization. WHO eLENA (web page) 2024Guideline / position statementindependent cross-checkabstract checked★ key studyWHO recommends that pregnant women take daily iron (30-60 mg) and folic acid (0.4 mg), starting folic acid ideally before conception.
WHO recommends daily iron (30-60 mg) and folic acid for all pregnant women.
Does the study support the specific claim? No · Methodological quality: high · Certainty of evidence: see overall assessment of the claim
Original publication · Scientific details
Study explained simply
- What did the researchers want to find out?
To state WHO's recommendation on iron and folic acid in pregnancy.
- How was the study done?
Guideline recommendation based on systematic reviews.
- How many people, animals or samples were studied?
Not applicable.
- What was actually found?
Daily iron and folic acid recommended for all pregnant women.
- How large was the observed effect?
Not applicable.
- What do the results mean in everyday life?
Taking iron and folic acid in pregnancy is standard, recommended care.
- What are the study's limitations?
Summary page only; national practice varies.
- What does it say about Elawady's specific claim?
Directly contradicts banning iron or folic acid in pregnancy.
- Do the results apply to Germany and Europe?
Global.
- What can explicitly not be concluded from this study?
Does not replace individual medical advice.
-
Treating iron-deficiency anaemia in pregnancy
Reveiz L et al.. Cochrane Database Syst Rev 2011 · PMID 21975735 · DOI 10.1002/14651858.CD003094.pub3Systematic reviewindependent cross-checkabstract checkedIron tablets improved blood counts in anaemic pregnant women but often upset the stomach; good trials on outcomes for mother and baby are scarce.
Oral iron corrects anaemia in pregnant women with iron-deficiency anaemia; trial quality is low.
Does the study support the specific claim? No · Methodological quality: moderate · Certainty of evidence: see overall assessment of the claim
Original publication · Scientific details
Study explained simply
- What did the researchers want to find out?
To compare treatments for iron-deficiency anaemia in pregnancy.
- How was the study done?
Cochrane review of 23 trials.
- How many people, animals or samples were studied?
3,198 women.
- What was actually found?
Oral iron improves blood values; side effects common; little data on clinical outcomes.
- How large was the observed effect?
Anaemia RR 0.38 (0.26-0.55) in one trial.
- What do the results mean in everyday life?
Iron works to correct anaemia, but side effects need managing.
- What are the study's limitations?
Small, weak trials.
- What does it say about Elawady's specific claim?
Contradicts withholding iron from anaemic pregnant women; acknowledges side effects.
- Do the results apply to Germany and Europe?
Applicable.
- What can explicitly not be concluded from this study?
Cannot show the best dose or route.
No study in this group is marked as key.
Studies with mixed or unclear results (1)
-
Diet to treat anaemia in pregnancy
Skolmowska D et al.. Nutrients 2022 · PMID 35893877 · DOI 10.3390/nu14153023Systematic reviewindependent cross-checkabstract checkedSeven small trials suggest that diet changes, fortified foods or counselling can raise haemoglobin in pregnancy, but the evidence is weak.
Dietary approaches (often with iron-fortified foods) may raise haemoglobin; does not support withholding iron from anaemic pregnant women.
Does the study support the specific claim? Partly · Methodological quality: low · Certainty of evidence: see overall assessment of the claim
Original publication · Scientific details
Study explained simply
- What did the researchers want to find out?
To test food-based approaches against anaemia in pregnancy.
- How was the study done?
Systematic review of 7 trials.
- How many people, animals or samples were studied?
Not stated.
- What was actually found?
Dietary interventions improved haemoglobin.
- How large was the observed effect?
Not pooled.
- What do the results mean in everyday life?
Diet matters, but it is not shown to replace iron tablets when anaemia is present.
- What are the study's limitations?
Few, biased trials; fortified foods contain added iron.
- What does it say about Elawady's specific claim?
Partly supports the idea that diet matters; does not support the ban.
- Do the results apply to Germany and Europe?
Applicable.
- What can explicitly not be concluded from this study?
Cannot show diet alone is enough in anaemia.
No study in this group is marked as key.
Regional context
Germany / EU
German maternity care routinely checks haemoglobin and treats iron deficiency.
Egypt
A 2025 meta-analysis of 18 Egyptian studies (14,548 women; I-LEG-127) found anaemia in 49% of pregnant women (65% in the third trimester); lack of iron supplementation was associated with anaemia (OR 2.59). The claim therefore concerns a very common condition in Egypt.
What applies in my country?
General scientific assessment
False This claim is false: iron tablets prevent and correct iron-deficiency anaemia in pregnancy, WHO recommends them, and refusing iron to an anaemic pregnant woman can harm mother and baby.
This statement concerns biological or medical relationships. The scientific assessment above applies regardless of the country; country-specific food data do not change it.
References
- Daily oral iron supplementation during pregnancy.. Peña-Rosas JP et al.. Cochrane Database Syst Rev 2015 · PMID 26198451 · DOI 10.1002/14651858.CD004736.pub5
- Daily oral iron supplementation during pregnancy.. Finkelstein JL et al.. Cochrane Database Syst Rev 2024 · PMID 39145520 · DOI 10.1002/14651858.CD004736.pub6
- Anaemia, prenatal iron use, and risk of adverse pregnancy outcomes: systematic review and meta-analysis.. Haider BA et al.. BMJ 2013 · PMID 23794316 · DOI 10.1136/bmj.f3443
- Anemia in pregnancy: a systematic review and meta-analysis of prevalence, determinants, and health impacts in Egypt.. Azzam A et al.. BMC Pregnancy Childbirth 2025 · PMID 39810098 · DOI 10.1186/s12884-024-07111-9
- The benefits and harms of oral iron supplementation in non-anaemic pregnant women: a systematic review and meta-analysis.. Watt A et al.. Fam Pract 2025 · PMID 39834271 · DOI 10.1093/fampra/cmae079
- Daily iron and folic acid supplementation during pregnancy (WHO e-Library of Evidence for Nutrition Actions, intervention page, last updated 26 July 2024). World Health Organization. WHO eLENA (web page) 2024
- Treatments for iron-deficiency anaemia in pregnancy.. Reveiz L et al.. Cochrane Database Syst Rev 2011 · PMID 21975735 · DOI 10.1002/14651858.CD003094.pub3
- Effectiveness of Dietary Interventions in Prevention and Treatment of Iron-Deficiency Anemia in Pregnant Women: A Systematic Review of Randomized Controlled Trials.. Skolmowska D et al.. Nutrients 2022 · PMID 35893877 · DOI 10.3390/nu14153023